Cincinnati Business Courier: Cincinnati Children’s lands third largest grant ever
UC faculty partner with Cincinnati Children's
Cincinnati Business Courier reports that Cincinnati Children’s has landed $28 million in federal funding – the hospital's third-largest single grant ever – to establish a data management and coordinating center for an agency that oversees researchers seeking cures for hundreds of rare diseases.
The five-year grant from the National Center for Advancing Translational Sciences, one of the National Institutes of Health, will fund a coordinating center to facilitate studies involving thousands of scientists across the United States and 22 other nations.
The center based at the hospital in Avondale will collect, organize, share and analyze big data about rare diseases that are often disabling or fatal. The data management and coordinating center will be led by three senior Children’s scientists and University of Cincinnati College of Medicine faculty members. They include Eileen King and Dr. Maurizio Macaluso, both professors in the UC Department of Pediatrics, and Peter White, professor and chair of the UC Department of Biomedical Informatics.
Read the Business Courier Story online
Learn more about how University of Cincinnati faculty will also support this work.
Photo courtesy of Cincinnati Children's
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.